Challenges in IBD research: update on progress and prioritization of the CCFA's research agenda.
作者信息
Denson Lee A, Long Millie D, McGovern Dermot P B, Kugathasan Subra, Wu Gary D, Young Vincent B, Pizarro Theresa T, de Zoeten Edwin F, Stappenbeck Thaddeus S, Plevy Scott E, Abraham Clara, Nusrat Asma, Jobin Christian, McCole Declan F, Siegel Corey A, Higgins Peter D R, Herfarth Hans H, Hyams Jeffrey, Sandborn William J, Loftus Edward V, Kappelman Michael D, Lewis James D, Parkos Charles A, Sartor R Balfour
机构信息
Division of Pediatric Gastroenterology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, OH, USA.
出版信息
Inflamm Bowel Dis. 2013 Mar-Apr;19(4):677-82. doi: 10.1097/MIB.0b013e31828134b3.
Abstract
摘要
相似文献
1
Challenges in IBD research: update on progress and prioritization of the CCFA's research agenda.炎症性肠病研究中的挑战：CCFA研究议程的进展与优先事项更新
Inflamm Bowel Dis. 2013 Mar-Apr;19(4):677-82. doi: 10.1097/MIB.0b013e31828134b3.
2
Challenges in IBD research: Assessing progress and rethinking the research agenda.炎症性肠病研究中的挑战：评估进展与重新思考研究议程。
Inflamm Bowel Dis. 2008 May;14(5):687-708. doi: 10.1002/ibd.20371.
3
IBD legislation introduced.炎症性肠病相关立法出台。
Gastroenterology. 2007 Apr;132(4):1215. doi: 10.1053/j.gastro.2007.03.022.
4
Challenges in IBD Research: updating the scientific agendas.
Inflamm Bowel Dis. 2003 May;9(3):137-53. doi: 10.1097/00054725-200305000-00001.
5
Crohn's & Colitis Foundation Engaging IBD Patients for 50 Years.克罗恩病与结肠炎基金会五十年来一直致力于让炎症性肠病患者参与其中。
Inflamm Bowel Dis. 2018 Apr 23;24(5):930-931. doi: 10.1093/ibd/izy071.
6
Inflammatory bowel disease in the 21(st) century in China: turning challenges into opportunities.21 世纪的中国炎症性肠病：化挑战为机遇。
J Dig Dis. 2012 Apr;13(4):195-9. doi: 10.1111/j.1751-2980.2012.00579.x.
7
Inflammatory bowel disease: diagnosis and research trends: the clinical lab is playing an increasingly important role.炎症性肠病：诊断与研究趋势：临床实验室正发挥着越来越重要的作用。
MLO Med Lab Obs. 2012 Aug;44(8):8, 10, 12; quiz 14.
8
Challenges in IBD Research: Pragmatic Clinical Research.炎症性肠病研究面临的挑战：实用临床研究。
Inflamm Bowel Dis. 2019 May 16;25(Suppl 2):S40-S47. doi: 10.1093/ibd/izz085.
9
State-of-the-art of irritable bowel syndrome and inflammatory bowel disease research in 2008.2008年肠易激综合征与炎症性肠病的研究现状
World J Gastroenterol. 2008 May 7;14(17):2625-9. doi: 10.3748/wjg.14.2625.
10
[Research in inflammatory bowel disease - an obsolescent model or new perspectives?].[炎症性肠病的研究——过时的模型还是新的视角？]
Z Gastroenterol. 2012 Apr;50(4):363. doi: 10.1055/s-0031-1299364. Epub 2012 Apr 1.
引用本文的文献
1
New Insights into the Role of Oral Microbiota Dysbiosis in the Pathogenesis of Inflammatory Bowel Disease.口腔微生物失调在炎症性肠病发病机制中的作用的新见解。
Dig Dis Sci. 2022 Jan;67(1):42-55. doi: 10.1007/s10620-021-06837-2. Epub 2021 Feb 1.
2
From clinical practice guideline development to trial registration: A systematic investigation of research pipeline for inflammatory bowel disease.从临床实践指南制定到试验注册：炎症性肠病研究流程的系统调查
Indian J Gastroenterol. 2019 Jun;38(3):247-262. doi: 10.1007/s12664-019-00965-4. Epub 2019 Jul 3.
3
Crohn's Disease: Potential Drugs for Modulation of Autophagy.克罗恩病：自噬调控的潜在药物。
Medicina (Kaunas). 2019 May 29;55(6):224. doi: 10.3390/medicina55060224.
4
Cohort profile of the PRoteomic Evaluation and Discovery in an IBD Cohort of Tri-service Subjects (PREDICTS) study: Rationale, organization, design, and baseline characteristics.三军受试者炎症性肠病队列蛋白质组学评估与发现（PREDICTS）研究的队列概况：原理、组织、设计和基线特征
Contemp Clin Trials Commun. 2019 Mar 26;14:100345. doi: 10.1016/j.conctc.2019.100345. eCollection 2019 Jun.
5
Pediatric Inflammatory Bowel Disease Clinical Innovations Meeting of the Crohn's & Colitis Foundation: Charting the Future of Pediatric IBD.儿科炎症性肠病临床创新会议：绘制儿科 IBD 的未来。
Inflamm Bowel Dis. 2019 Jan 1;25(1):27-32. doi: 10.1093/ibd/izy205.
6
Molecular profiling of mucosal tissue associated microbiota in patients manifesting acute exacerbations and remission stage of ulcerative colitis.溃疡性结肠炎急性发作和缓解期患者黏膜组织相关微生物群的分子特征分析。
World J Microbiol Biotechnol. 2018 May 23;34(6):76. doi: 10.1007/s11274-018-2449-0.
7
Establishment and Development of the First Biobank of Inflammatory Bowel Disease, Suspected to Primary Immunodeficiency Diseases in Iran.伊朗首个炎症性肠病生物样本库的建立与发展，该生物样本库疑似与原发性免疫缺陷病相关。
Adv Biomed Res. 2018 Mar 27;7:45. doi: 10.4103/abr.abr_278_16. eCollection 2018.
8
Environmental factors regulate Paneth cell phenotype and host susceptibility to intestinal inflammation in Irgm1-deficient mice.环境因素调节 Irgm1 缺陷型小鼠潘氏细胞表型和宿主对肠道炎症的易感性。
Dis Model Mech. 2018 Feb 7;11(2):dmm031070. doi: 10.1242/dmm.031070.
9
Inflammatory Bowel Disease Drugs: A Focus on Autophagy.炎症性肠病药物：聚焦自噬
J Crohns Colitis. 2017 Jan;11(1):118-127. doi: 10.1093/ecco-jcc/jjw127. Epub 2016 Jul 5.
10
Collecting Biospecimens From an Internet-Based Prospective Cohort Study of Inflammatory Bowel Disease (CCFA Partners): A Feasibility Study.从基于互联网的炎症性肠病前瞻性队列研究（CCFA合作伙伴）中收集生物标本：一项可行性研究。
JMIR Res Protoc. 2016 Jan 5;5(1):e3. doi: 10.2196/resprot.5171.
本文引用的文献
1
Risk of natalizumab-associated progressive multifocal leukoencephalopathy.纳武利尤单抗相关进行性多灶性白质脑病的风险。
N Engl J Med. 2012 May 17;366(20):1870-80. doi: 10.1056/NEJMoa1107829.
2
Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease.炎症性肠病患者患黑色素瘤和非黑色素瘤皮肤癌的风险。
Gastroenterology. 2012 Aug;143(2):390-399.e1. doi: 10.1053/j.gastro.2012.05.004. Epub 2012 May 11.
3
The development of LTi cells.LTi 细胞的发育。
Curr Opin Immunol. 2012 Apr;24(2):178-83. doi: 10.1016/j.coi.2012.02.003. Epub 2012 Mar 1.
4
Are Th17 cells in the gut pathogenic or protective?肠道中的 Th17 细胞是致病的还是保护性的？
Mucosal Immunol. 2012 Jan;5(1):4-6. doi: 10.1038/mi.2011.51. Epub 2011 Nov 9.
5
HNF4α and CDH1 are associated with ulcerative colitis in a Dutch cohort.HNF4α 和 CDH1 与荷兰队列中的溃疡性结肠炎有关。
Inflamm Bowel Dis. 2011 Aug;17(8):1714-8. doi: 10.1002/ibd.21541. Epub 2010 Nov 28.
6
Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease.接受硫唑嘌呤治疗炎症性肠病的患者发生非黑素瘤皮肤癌的风险增加。
Gastroenterology. 2011 Nov;141(5):1621-28.e1-5. doi: 10.1053/j.gastro.2011.06.050. Epub 2011 Jun 25.
7
Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification.儿科版蒙特利尔炎症性肠病分类：巴黎分类。
Inflamm Bowel Dis. 2011 Jun;17(6):1314-21. doi: 10.1002/ibd.21493. Epub 2010 Nov 8.
8
The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota.Toll 样受体 2 通路建立了人体微生物群共生体的定植。
Science. 2011 May 20;332(6032):974-7. doi: 10.1126/science.1206095. Epub 2011 Apr 21.
9
Charting a course for genomic medicine from base pairs to bedside.为基因组医学绘制从碱基对到床边的路线图。
Nature. 2011 Feb 10;470(7333):204-13. doi: 10.1038/nature09764.
10
Induction of colonic regulatory T cells by indigenous Clostridium species.肠道共生梭菌诱导结肠调节性 T 细胞。
Science. 2011 Jan 21;331(6015):337-41. doi: 10.1126/science.1198469. Epub 2010 Dec 23.
Zotero 插件